Screener
Bio-Techne TECH Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Bio-Techne’s 10-Q, filed November 5, 2025.
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q3 2025
- Accession
- 0001104659-25-107053
| Line item | Quarter Ended / September 30, 2025 | Quarter Ended / September 30, 2024 |
|---|---|---|
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Cash dividends | (12,444) | (12,688) |
| Proceeds from stock option exercises | 23,495 | 25,101 |
| Repurchases of common stock | (24) | — |
| Repayments of long-term debt | (46,000) | (19,000) |
| Taxes paid on RSUs and net share settlements | (9,231) | (4,984) |
| Net cash provided by (used in) financing activities | (44,204) | (11,571) |
| Effect of exchange rate changes on cash and cash equivalents | (1,210) | 5,115 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's share buybacks?
- Bio-Techne (TECH) reported share buybacks of $24K in Q3 2025.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about Bio-Techne's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude